Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07671417
EARLY_PHASE1
Imaging Study in Metastatic Clear Cell RCC.
Sponsor: RayzeBio, Inc.
View on ClinicalTrials.gov
Summary
This imaging study aims to assess the feasibility, biodistribution, and dosimetry of the imaging agent in Subjects with Metastatic Clear Cell Renal Cell Cancer (RCC).
Official title: A Phase 0 Imaging Study to Assess the Feasibility, Biodistribution, and Dosimetry of the Imaging Agent in Subjects With Metastatic Clear Cell Renal Cell Cancer (RCC).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-06
Completion Date
2027-01
Last Updated
2026-07-16
Healthy Volunteers
No
Interventions
DIAGNOSTIC_TEST
RYZ512
Imaging Agent
Locations (1)
Research Facility
Christchurch, New Zealand